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showed signiﬁcantly higher values of resistance/height (R/H;
p < 0.01) and reactance/height (X/H; p < 0.01), and a lower
phase angle (p < 0.01). Moreover we show a signiﬁcant cor-
relation between appendicular mass and resistance/height
(r = +0.151; p < 0.0001) and reactance/height (r = +0.047;
p = 0.04). GDF-15, Activin A and IL-1 were not correlated with
muscle wasting.
Conclusions: BIVA detected muscle-mass variations in pa-
tients with muscle wasting. These procedures are promising
tools for screening for muscle wasting in routine practice. Pa-
tients with HF showed reduced exercise capacity and reduced
quality of life and both are correlated with each other. More-
over we have shown that patients with cachexia showed
higher GDF-15 and Interleukin-1 levels.
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Introduction: Anorexia and the satiating effects of dietary
protein are partly responsible for deﬁciencies in protein (PI)
and energy intakes (EI), which are contributing factors to
age-related sarcopenia. We have demonstrated that essential
amino acids (EAA) supplements facilitate an increase in PI and
EI of older women. However, it is not known whether supple-
mentation with different forms of protein supplements pro-
viding equivalent amounts of EAA can be as equally
effective at increasing EI. We therefore investigated the ef-
fect of supplements matched in EAA content (7.5 g) on EI
and appetite.
Methods: Ten women aged 69.2 ± 2.7 years, completed three
trials in a randomized, crossover design. Composite appetite
scores, peptide YY, and insulin responses to a 200 ml whey
protein (WP) isolate (275 kJ), a 50 ml EAA gel (478 kJ) or a
control (CON) were investigated over one hour, followed by
an ad libitum breakfast.
Results: EI at breakfast (CON 1957 ± 713,WP 1413 ± 623, EAA
1963 ± 611 kJ) was higher in the CON and EAA than the WP
(both P = 0.006). After accounting for supplement energy
content, EI in the EAA was higher than the CON
(P = 0.0006) and WP (P = 0.0008). Time-averaged area under
the curve for composite appetite scores (CON 74 ± 20, WP
50 ± 22, EAA 60 ± 16 mm) was higher in CON than WP
(P = 0.015). Time-averaged area under the curve for peptide
tyrosine tyrosine (CON 87 ± 13, WP 119 ± 27, EAA
97 ± 22 pg·mL-1) was higher in WP than CON (P = 0.009)
and EAA (P = 0.012).
Conclusions: Supplementation with WP facilitated an in-
crease in PI, whereas supplementation with an EAA gel facil-
itated an increase in both PI and EI, therefore may be
potential means for addressing nutritional age-related
sarcopenia.
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Introduction: Dietary supplementation with ω-3-polyunsatu-
rated fatty acids (PUFAs) has shown beneﬁcial effects on can-
cer and treatment outcomes. Compared to eicosapentaenoic
acid (EPA) and docosahexaenoic acid (DHA), the role of ω-3-
PUFA docosapentaenoic acid (DPA) has been studied less.
We hypothesize that DPA could have similar effects as EPA
and DHA in cancer and during its treatment.
Methods: C26-adenocarcinoma cells were pre-treated
(4 days) with EPA, DHA or DPA (50 μM) and treated with
doxorubicin or cisplatin. Cellular PUFA incorporation and
chemo-sensitivity was measured by cell gas-chromatography,
cell viability (WST) and apoptosis (caspase-3/7). Subse-
quently, incorporation of PUFAs in tumour and muscle tissue
was studied in a C26-tumour-bearing (TB) mouse model after
supplementation with EPA-containing diet supplements (ﬁsh-
oil, pure-EPA or tuna-oil). In healthy volunteers, PUFA incor-
poration was measured in plasma, RBC and WBC at ﬁve
timepoints following a nutritional supplement intervention
containing ﬁsh-oil for 7 days (Faber et al 2011).
Results: Both EPA and DPA showed similar chemotherapy-en-
hancing properties by increasing chemotherapy sensitivity in
C26-adenocarcinoma cells. DPA incorporation was signiﬁ-
cantly increased in cells treated with EPA and DPA
(P < 0.0001) when compared to control treatment. In TB-
mice, supplementation with ﬁsh-oil and pure-EPA, both high
in EPA content and low in DPA, resulted in a twice as high in-
corporation of DPA in tumour and muscle tissue when com-
pared to EPA. In line with the preclinical results, healthy
volunteers showed a signiﬁcant increase in EPA and DPA in
WBC and plasma (P < 0.001) following supplementation with
a ﬁsh-oil containing nutritional intervention.
Conclusions: Supplementation with EPA or EPA-containing
supplements leads to increased cellular EPA and DPA. High
DPA incorporation is mainly driven by the elongation of incor-
porated EPA. Both EPA and DPA supplementation showed
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